PH
Padagis Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Naloxone Access Program | Opioid Overdose Reversal | Commercial |
| Extended Topicals Portfolio | Various (Dermatology, Pain, etc.) | Development & Commercial |
Leadership Team at Padagis
BR
Bryan Reasons
Executive Vice President and Chief Financial Officer
VG
Vishal Gupta
Executive Vice President Chief Scientific Officer
OS
Ofir Seva
Executive Vice President and Chief Operating Officer
SS
Sujeet Singh
Executive Vice President and Chief Growth Officer